Philip J Mease1, Amit Garg2, Philip S Helliwell2, Jane J Park2, Dafna D Gladman2. 1. From Seattle Rheumatology Associates, Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington; Department of Dermatology, Hofstra North Shore LIJ School of Medicine, Hempstead, New York, USA; University of Leeds, Leeds, UK, and Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; University of Toronto; Toronto Western Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada.P.J. Mease, MD, Seattle Rheumatology Associates, director, Rheumatology Research, Swedish Medical Center, and clinical professor, University of Washington School of Medicine; A. Garg, MD, Department of Dermatology, Hofstra North Shore LIJ School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds; and Bradford Hospitals NHS Foundation Trust; J.J. Park, MD, Seattle Rheumatology Associates, and University of Washington School of Medicine; D.D. Gladman, MD, FRCPC, professor of medicine, University of Toronto, senior scientist, Toronto Western Research Institute, and director, Psoriatic Arthritis Program, University Health Network. pmease@philipmease.com. 2. From Seattle Rheumatology Associates, Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington; Department of Dermatology, Hofstra North Shore LIJ School of Medicine, Hempstead, New York, USA; University of Leeds, Leeds, UK, and Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; University of Toronto; Toronto Western Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada.P.J. Mease, MD, Seattle Rheumatology Associates, director, Rheumatology Research, Swedish Medical Center, and clinical professor, University of Washington School of Medicine; A. Garg, MD, Department of Dermatology, Hofstra North Shore LIJ School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds; and Bradford Hospitals NHS Foundation Trust; J.J. Park, MD, Seattle Rheumatology Associates, and University of Washington School of Medicine; D.D. Gladman, MD, FRCPC, professor of medicine, University of Toronto, senior scientist, Toronto Western Research Institute, and director, Psoriatic Arthritis Program, University Health Network.
Abstract
OBJECTIVE: To describe a research project to develop simple clinical criteria to aid in the identification of inflammatory arthritis, enthesitis, dactylitis, and spondylitis and distinguish these from non-inflammatory conditions. The criteria are particularly intended to aid non-rheumatologists, e.g., dermatologists, who need assistance identifying psoriatic arthritis in patients with psoriasis, but may be useful to all clinicians in properly diagnosing rheumatologic conditions. METHODS: The proposed research methodology includes the use of a nominal group exercise among expert clinicians and patient focus groups, Delphi exercises among clinicians and patients, application of criteria test sets to a small group of representative patients with inflammatory and non-inflammatory musculoskeletal conditions, and validation by application of optimal criteria sets to large groups of patients with inflammatory and noninflammatory conditions. RESULTS: Examples of elements to describe inflammatory conditions derived from a nominal group exercise conducted at the 2013 GRAPPA annual meeting are described, along with planned project activities. CONCLUSION: This project will lead to the development of practical criteria to aid in the diagnosis and appropriate clinical care of patients with chronic inflammatory musculoskeletal conditions.
OBJECTIVE: To describe a research project to develop simple clinical criteria to aid in the identification of inflammatory arthritis, enthesitis, dactylitis, and spondylitis and distinguish these from non-inflammatory conditions. The criteria are particularly intended to aid non-rheumatologists, e.g., dermatologists, who need assistance identifying psoriatic arthritis in patients with psoriasis, but may be useful to all clinicians in properly diagnosing rheumatologic conditions. METHODS: The proposed research methodology includes the use of a nominal group exercise among expert clinicians and patient focus groups, Delphi exercises among clinicians and patients, application of criteria test sets to a small group of representative patients with inflammatory and non-inflammatory musculoskeletal conditions, and validation by application of optimal criteria sets to large groups of patients with inflammatory and noninflammatory conditions. RESULTS: Examples of elements to describe inflammatory conditions derived from a nominal group exercise conducted at the 2013 GRAPPA annual meeting are described, along with planned project activities. CONCLUSION: This project will lead to the development of practical criteria to aid in the diagnosis and appropriate clinical care of patients with chronic inflammatory musculoskeletal conditions.
Authors: Ying Ying Leung; Alexis Ogdie; Ana-Maria Orbai; William Tillett; Laura C Coates; Vibeke Strand; Philip Mease; Dafna D Gladman Journal: Front Med (Lausanne) Date: 2018-09-06
Authors: I Belinchón; L Salgado-Boquete; A López-Ferrer; M Ferran; P Coto-Segura; R Rivera; D Vidal; L Rodríguez; P de la Cueva; R Queiro Journal: Actas Dermosifiliogr (Engl Ed) Date: 2020-07-10